+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 45Years +
All Genders
ID06919302

Digital Heart Health Program Added to Standard Care to Lower Heart Disease Risk and Major Cardiovascular Events in Adults

Led by University of Toronto · Updated on 2025-11-26

1100

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the impact of adding a digital heart health program to standard care for people with cardiovascular diseases and risk factors, including those with dyslipidemia and major cardiovascular events. The study focuses on adults aged 45 and older who are on stable statin therapy. It aims to see if this digital program can help reduce blood cholesterol and other heart disease risks over one year and lower major cardiovascular events over seven years. After seven years, the study shifts to a longer-term observation phase to assess lasting effects. Participants will be randomly assigned to either continue with standard care alone or receive standard care plus access to a digital heart health program. This program includes a web-based app with interactive features like goal setting and gamification, supported by sixteen online group sessions in the first year and provision of key study foods. Standard care follows guideline-based best practices. The intervention phase lasts seven years, after which the study continues as a cohort study where all participants can use the app. During the study, participants complete online questionnaires and provide blood samples at local clinics. They will also wear a continuous glucose monitor and a wrist activity tracker at three points during the first year. Follow-up bloodwork and questionnaires continue every four years during the cohort phase. Researchers will measure cholesterol reductions, cardiovascular events, dietary adherence, blood lipids, blood pressure, inflammation, medication changes, glucose control, insulin resistance, body measurements, and cost-effectiveness over the study duration, which runs until 2035.

CONDITIONS

Brief Title

The Effect of a Digital Heart Health App and Lifestyle Intervention for Heart Disease in Primary Care.

Research Team

L

Laura Chiavaroli, PhD

J

John L Sievenpiper, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here